← All investors

I

Firm & fund profile / Sourced portfolio

IVP

Tracked participation in 8 Atlas companies, with 5 explicitly attributed leads.

Firm website ↗

8portfolio companies

18round participations

5lead positions

$611.6Mled round total

Conviction

Most recent leads

The latest rounds this investor is sourced as leading, newest first.

Feb 2026BasetenSeries E$300Mat $5B valuation Oct 2025LangChainSeries B$125Mat $1.3B valuation Nov 2024CradleSeries B$73M Jan 2024PerplexitySeries B$73.6M UndatedBasetenSeries B$40M

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

BBaseten$13BSep 2025 → Jun 20265 rounds2 led—

SSuno$5.4BJun 2026 → Jun 20261 roundParticipant—

LLangChain$1.3BOct 2025 → Oct 20251 round1 led—

GGlean$7.2BFeb 2024 → Jun 20253 roundsParticipant—

AAbridgeApplicationsAbridge is a private, enterprise-grade healthcare AI company focused on “clinical conversation intelligence”:…$757.5MraisedRecent roundsStrategic / corporate minority investment (undisclosed amount) · Jun 2026Eli Lilly and Company, NVIDIASeries E · Jun 2025$300M · led by Andreessen HorowitzSeries D · Feb 2025$250M · Bessemer Venture Partners, California Health Care Foundation +10Abridge—Feb 2024 → Feb 20252 roundsParticipant—

CCradle—Nov 2024 → Nov 20241 round1 led—

SSkydio$2.2BJul 2020 → Nov 20244 roundsParticipant—

PPerplexity—Jan 2024 → Jan 20241 round1 led—

DateCompanyRoundRaisedValuationRoleEvidence

Jun 22, 2026BBasetenSeries F$1.5B$13BParticipant

Jun 03, 2026SSunoSeries D$400M$5.4BParticipant

Feb 25, 2026BBasetenSeries C$75M—Participant

Feb 05, 2026BBasetenSeries E$300M$5BLead

Oct 20, 2025LLangChainSeries B$125M$1.3BLead

Sep 05, 2025BBasetenSeries D$150M—Participant

Jun 10, 2025GGleanSeries F$150M$7.2BParticipant

Feb 17, 2025AAbridgeApplicationsAbridge is a private, enterprise-grade healthcare AI company focused on “clinical conversation intelligence”:…$757.5MraisedRecent roundsStrategic / corporate minority investment (undisclosed amount) · Jun 2026Eli Lilly and Company, NVIDIASeries E · Jun 2025$300M · led by Andreessen HorowitzSeries D · Feb 2025$250M · Bessemer Venture Partners, California Health Care Foundation +10AbridgeSeries D$250M—Participant

Nov 26, 2024CCradleSeries B$73M—Lead

Nov 15, 2024SSkydioSeries E extension$170M—Participant

Sep 10, 2024GGleanSeries E$260M$4.6BParticipant

Feb 27, 2024GGleanSeries D$200M$2.2BParticipant

Feb 23, 2024AAbridgeApplicationsAbridge is a private, enterprise-grade healthcare AI company focused on “clinical conversation intelligence”:…$757.5MraisedRecent roundsStrategic / corporate minority investment (undisclosed amount) · Jun 2026Eli Lilly and Company, NVIDIASeries E · Jun 2025$300M · led by Andreessen HorowitzSeries D · Feb 2025$250M · Bessemer Venture Partners, California Health Care Foundation +10AbridgeSeries C$150M—Participant

Jan 04, 2024PPerplexitySeries B$73.6M—Lead

Feb 27, 2023SSkydioSeries E$230M$2.2BParticipant

Mar 01, 2021SSkydioSeries D$170M$1BParticipant

Jul 13, 2020SSkydioSeries C$100M—Participant

UndatedBBasetenSeries B$40M—Lead

DateCompanyRoundRaisedValuationRoleEvidence

Jun 22, 2026BBasetenSeries F$1.5B$13BParticipant

Jun 03, 2026SSunoSeries D$400M$5.4BParticipant

Feb 05, 2026BBasetenSeries E$300M$5BLead

Sep 10, 2024GGleanSeries E$260M$4.6BParticipant

Feb 17, 2025AAbridgeApplicationsAbridge is a private, enterprise-grade healthcare AI company focused on “clinical conversation intelligence”:…$757.5MraisedRecent roundsStrategic / corporate minority investment (undisclosed amount) · Jun 2026Eli Lilly and Company, NVIDIASeries E · Jun 2025$300M · led by Andreessen HorowitzSeries D · Feb 2025$250M · Bessemer Venture Partners, California Health Care Foundation +10AbridgeSeries D$250M—Participant

Feb 27, 2023SSkydioSeries E$230M$2.2BParticipant

Feb 27, 2024GGleanSeries D$200M$2.2BParticipant

Nov 15, 2024SSkydioSeries E extension$170M—Participant

Mar 01, 2021SSkydioSeries D$170M$1BParticipant

Sep 05, 2025BBasetenSeries D$150M—Participant

Jun 10, 2025GGleanSeries F$150M$7.2BParticipant

Feb 23, 2024AAbridgeApplicationsAbridge is a private, enterprise-grade healthcare AI company focused on “clinical conversation intelligence”:…$757.5MraisedRecent roundsStrategic / corporate minority investment (undisclosed amount) · Jun 2026Eli Lilly and Company, NVIDIASeries E · Jun 2025$300M · led by Andreessen HorowitzSeries D · Feb 2025$250M · Bessemer Venture Partners, California Health Care Foundation +10AbridgeSeries C$150M—Participant

Oct 20, 2025LLangChainSeries B$125M$1.3BLead

Jul 13, 2020SSkydioSeries C$100M—Participant

Feb 25, 2026BBasetenSeries C$75M—Participant

Jan 04, 2024PPerplexitySeries B$73.6M—Lead

Nov 26, 2024CCradleSeries B$73M—Lead

UndatedBBasetenSeries B$40M—Lead